{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T17:20:38Z","timestamp":1780593638049,"version":"3.54.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,20]]},"DOI":"10.7759\/cureus.74069","type":"journal-article","created":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T10:34:45Z","timestamp":1732098885000},"source":"Crossref","is-referenced-by-count":7,"title":["Efficacy and Safety of Optilume Drug-Coated Balloon for Urethral Stricture Treatment: A Systematic Review and Meta-Analysis"],"prefix":"10.7759","author":[{"given":"Peter","family":"Estaphanous","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed O","family":"Khalifa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youstina","family":"Makar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eursup.2015.10.002","article-title":"Incidence, causes, and complications of urethral stricture disease","volume":"15","author":"Lazzeri M","year":"2016","unstructured":"Lazzeri M, Sansalone S, Guazzoni G, Barbagli G. Incidence, causes, and complications of urethral stricture disease. European Urology Supplements. 2016, 15:2-6. 10.1016\/j.eursup.2015.10.002","journal-title":"European Urology Supplements"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2007.01.041","article-title":"Male urethral stricture disease","volume":"177","author":"Santucci RA","year":"2007","unstructured":"Santucci RA, Joyce GF, Wise M. Male urethral stricture disease. J Urol. 2007, 177:1667-74. 10.1016\/j.juro.2007.01.041","journal-title":"J Urol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-323-91199-3.00010-4","article-title":"Pathophysiology of urethral stricture: optimizing urethroplasty outcomes","author":"Cavalcanti A","year":"2022","unstructured":"Cavalcanti A, Schul A, Restreppo CF, Aldred JE. Pathophysiology of urethral stricture: optimizing urethroplasty outcomes. InSc Adv Recon Uro Tis Eng. 2022, 177-59. 10.1016\/B978-0-323-91199-3.00010-4","journal-title":"InSc Adv Recon Uro Tis Eng"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2009.05.023","article-title":"Etiology of urethral stricture disease in the 21st century","volume":"182","author":"Lumen N","year":"2009","unstructured":"Lumen N, Hoebeke P, Willemsen P, De Troyer B, Pieters R, Oosterlinck W. Etiology of urethral stricture disease in the 21st century. J Urol. 2009, 182:983-7. 10.1016\/j.juro.2009.05.023","journal-title":"J Urol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2016.07.087","article-title":"Male urethral stricture: American Urological Association guideline","volume":"197","author":"Wessells H","year":"2017","unstructured":"Wessells H, Angermeier KW, Elliott S, et al.. Male urethral stricture: American Urological Association guideline. J Urol. 2017, 197:182-90. 10.1016\/j.juro.2016.07.087","journal-title":"J Urol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1177\/2051415820933504","article-title":"The standard for the management of male urethral strictures in the UK: a consensus document","volume":"14","author":"Bugeja S","year":"2021","unstructured":"Bugeja S, Payne SR, Eardley I, Mundy AR. The standard for the management of male urethral strictures in the UK: a consensus document. Jr Clin Uro. 2021, 14:10-20. 10.1177\/2051415820933504","journal-title":"Jr Clin Uro"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.4103\/0970-1591.85445","article-title":"The current role of direct vision internal urethrotomy and self-catheterization for anterior urethral strictures","volume":"27","author":"Dubey D","year":"2011","unstructured":"Dubey D. The current role of direct vision internal urethrotomy and self-catheterization for anterior urethral strictures. Indian J Urol. 2011, 27:392-6. 10.4103\/0970-1591.85445","journal-title":"Indian J Urol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1590\/S1677-5538.IBJU.2020.0242","article-title":"Long term outcomes of one-stage augmentation anterior urethroplasty: a systematic review and meta-analysis","volume":"47","author":"Benson CR","year":"2021","unstructured":"Benson CR, Li G, Brandes SB. Long term outcomes of one-stage augmentation anterior urethroplasty: a systematic review and meta-analysis. Int Braz J Urol. 2021, 47:237-50. 10.1590\/S1677-5538.IBJU.2020.0242","journal-title":"Int Braz J Urol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/ijms231810519","article-title":"Prospects and challenges of electrospun cell and drug delivery vehicles to correct urethral stricture","volume":"23","author":"Farzamfar S","year":"2022","unstructured":"Farzamfar S, Elia E, Chabaud S, Naji M, Bolduc S. Prospects and challenges of electrospun cell and drug delivery vehicles to correct urethral stricture. Int J Mol Sci. 2022, 23:10.3390\/ijms231810519","journal-title":"Int J Mol Sci"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1089\/end.2024.0318","article-title":"Optilume(\u00ae) drug-coated balloon may lower the re-treatment rate postintervention for challenging urethral stricture disease in long-term follow-up: a prospective cohort study","author":"Alhamdani Z","year":"2024","unstructured":"Alhamdani Z, Ong S, Zhong W, Chin P. Optilume(\u00ae) drug-coated balloon may lower the re-treatment rate postintervention for challenging urethral stricture disease in long-term follow-up: a prospective cohort study. J Endourol. 2024, 10.1089\/end.2024.0318","journal-title":"J Endourol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.21957.1","article-title":"Recent advances in treatment of urethral stricture disease in men","volume":"9","author":"Mangir N","year":"2020","unstructured":"Mangir N, Chapple C. Recent advances in treatment of urethral stricture disease in men. F1000Res. 2020, 9:10.12688\/f1000research.21957.1","journal-title":"F1000Res"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15071813","article-title":"Treatment of peripheral artery disease using injectable biomaterials and drug-coated balloons: safety and efficacy perspective","volume":"15","author":"Qamar SU","year":"2023","unstructured":"Qamar SU, Spahi\u0107 L, Benoli\u0107 L, Zivanovic M, Filipovi\u0107 N. Treatment of peripheral artery disease using injectable biomaterials and drug-coated balloons: safety and efficacy perspective. Pharmaceutics. 2023, 15:10.3390\/pharmaceutics15071813","journal-title":"Pharmaceutics"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.2147\/RRU.S359872","article-title":"A drug-coated balloon treatment for urethral stricture disease: three-year results from the ROBUST I study","volume":"14","author":"Virasoro R","year":"2022","unstructured":"Virasoro R, DeLong JM, Estrella RE, Pichardo M, Rodriguez Lay R, Espino G, Elliott SP. A drug-coated balloon treatment for urethral stricture disease: three-year results from the ROBUST I study. Res Rep Urol. 2022, 14:177-83. 10.2147\/RRU.S359872","journal-title":"Res Rep Urol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/JU.0000000000004229","article-title":"Long-term outcomes of recurrent bulbar urethral stricture treatment with the Optilume drug-coated balloon: five-year results from the ROBUST I study","author":"DeLong J","year":"2024","unstructured":"DeLong J, Virasoro R, Pichardo M, Estrella R, Rodr\u00edguez Lay R, Espino G, Elliott S. Long-term outcomes of recurrent bulbar urethral stricture treatment with the Optilume drug-coated balloon: five-year results from the ROBUST I study. J Urol. 2024, 101097JU0000000000004229. 10.1097\/JU.0000000000004229","journal-title":"J Urol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.acuroe.2024.10.003","article-title":"Efficacy and safety of Optilume\u00ae paclitaxel-coated urethral dilatation balloon in real-life: experience in a Spanish multicenter study","author":"Ballesteros Ruiz C","year":"2024","unstructured":"Ballesteros Ruiz C, Campos-Juanatey F, Povo Mart\u00edn I, et al.. Efficacy and safety of Optilume\u00ae paclitaxel-coated urethral dilatation balloon in real-life: experience in a Spanish multicenter study. Actas Urol Esp (Engl Ed). 2024, 10.1016\/j.acuroe.2024.10.003","journal-title":"Actas Urol Esp (Engl Ed)"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1002\/bco2.312","article-title":"Optilume drug-coated balloon for anterior urethral stricture: 2-year results of the ROBUST III trial","volume":"5","author":"VanDyke ME","year":"2024","unstructured":"VanDyke ME, Morey AF, Coutinho K, et al.. Optilume drug-coated balloon for anterior urethral stricture: 2-year results of the ROBUST III trial. BJUI Compass. 2024, 5:366-73. 10.1002\/bco2.312","journal-title":"BJUI Compass"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/S2666-1683(24)00976-5","article-title":"P049 real-world experience with Optilume for urethral stricture management: a retrospective analysis","volume":"69","author":"Dabbas M","year":"2024","unstructured":"Dabbas M, Payne A, Marantidis J, Shaw N, Venkatesan K. P049 real-world experience with Optilume for urethral stricture management: a retrospective analysis. Euro Uro Opn Sci. 2024, 69:74. 10.1016\/S2666-1683(24)00976-5","journal-title":"Euro Uro Opn Sci"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.cont.2023.100649","article-title":"","volume":"6","author":"Castellucci R","year":"2023","unstructured":"Castellucci R, Gatti L, Minore A, et al.. Continence (Amsterdam). 2023, 6:100649. 10.1016\/j.cont.2023.100649","journal-title":"Continence (Amsterdam)"},{"key":"ref19","doi-asserted-by":"crossref","DOI":"10.48083\/MLXK5817","article-title":"One-year outcomes of the ROBUST II study evaluating the use of a drug-coated balloon for treatment of urethral stricture","volume":"3","author":"DeLong JM","year":"2022","unstructured":"DeLong JM, Ehlert MJ, Erickson BA, et al.. One-year outcomes of the ROBUST II study evaluating the use of a drug-coated balloon for treatment of urethral stricture. Soci\u00e9t\u00e9 Internationale d\u2019Urologie Journal. 2022, 3:21-7.","journal-title":"Soci\u00e9t\u00e9 Internationale d\u2019Urologie Journal"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/319420-efficacy-and-safety-of-optilume-drug-coated-balloon-for-urethral-stricture-treatment-a-systematic-review-and-meta-analysis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T10:34:47Z","timestamp":1732098887000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/319420-efficacy-and-safety-of-optilume-drug-coated-balloon-for-urethral-stricture-treatment-a-systematic-review-and-meta-analysis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,20]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.74069","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11,20]]}}}